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Abstract 
Background: To identify different risk factors for 
female infertility including hormonal imbalance 
(FSH, LH and Prolactin)  
Methods: Infertile women were enrolled in this 
prospective study. A questionnaire was designed to 
collect information regarding socio-demographic and 
clinical characteristics of the study participants.  
Serum FSH, LH and Prolactin levels were estimated 
between 1-5 days of post menstrual period.  
Independent sample t- test, Spearman correlation 
and multivariate logistic regression were performed 
to find the association of different risk factors with 
female infertility.   
Results: Highest percentage (57.7%) of infertile 
females was in the age bracket of 26 to 35 years. The 
prevalence of primary infertility was 60.4% . Mean 
levels of LH and prolactin were significantly higher 
in women with primary infertility compared to those 
with secondary infertility. No significant difference 
was observed in the mean level of FSH . A 
significant positive correlation was found between 
infertility and age , marital history and infertility 
duration. On multivariate logistic regression 
analysis women with secondary infertility were 
more likely to be 
hypertensive(OR=2.126,95%CI:1.020-4.474, p-
value0.044), using contraceptive OR  = 5.876, 95% CI: 
2.491–13.86, p-value .001),have hyperprolactenemia 
(OR=1.289,95%CI:0.960-1.996,p-value0.001) and have 
marital history of more than 16 years 
OR=12.166,95%CI:5.048-29.322, p-value0.001). 
Conclusion:Highest prevalence of infertility was 
seen in the age group of 26-35 years. Advanced age, 
hypertension, hyperprolactemia, use of contraceptive 
 and marital history of more than 16 years   are 
significantly associated with female infertility  
Key Words: Infertility, Hypertension, 
Hyperprolactenemia, Luteinizing hormone, Follicle-
stimulating hormone. 
Introduction 
Infertility is multi-factorial problem that affects 
millions of females globally. Implications of hormonal 
imbalance and other risk factors in female infertility 
are an interesting area that requires to be explored in 
the recent times. Infertility is a global health concern 
affecting millions of women. It is defined as failure to 
achieve a clinical pregnancy after12 month or more of 
regular unprotected sexual intercourse. 1-3 Infertility 
can be classified as either primary or secondary. In the 
primary infertility, a couple has never been able to 
conceive. Secondary infertility is the case where there 
is a difficulty in conceiving after already having 
conceived.4 Globally,   50–80 millions of women are 
currently affected by this pathology and 25% of the 
couples in developing nations are affected by 
infertility.5,6 Infertility rates varies among countries 
ranging from 5 to 8% in developed countries and from 
5.8% to 44.2% in developing countries.7 There is 
unequivocal evidence that infertility is a major health 
issue in Asian countries. 8  Prevalence of infertility in 
Pakistan is estimated to be 22%  inclusive of 4% 
primary and 18% secondary infertility, ultimately 
affecting  one in every five married couples.9  
 Numerous genetic, physiological, environmental and 
acquired factors have been linked with infertility, 
including being 35 years old or more, a history of 
pelvic inflammatory disease,  hormonal imbalance, 
galactorrhea, obesity, surgical history, hypertension, 
T.B, diabetes, thyroid disorders and  life  style 
practices.10 Ovulation is the primary requirement for 
conception. Obesity contributes to an-ovulation and 
menstrual irregularities, culminating in reduced 
conception rates.11 Polycystic ovary Syndrome (POS) ,a 
hormonal disorder described by hyperandrogenism  is 
 another important factor  for anovulation.12,13  
Prevalance of PCOS is estimatedto be  4-25%  among 
Lower ovarian reserves leads to reduced fertility at 
younger ages in Asian women. 14 The  key hormones  
for female infertility workup includes follicle 
stimulating hormone (FSH),leutinizing 
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hormone(LH),prolactin (PRL) and thyroid stimulating 
hormones(TSH). An excess or deficiency of any of 
these hormone can cause anovulation and infertility. In 
hypothyroidism, elevated concentration of TSH and 
PRL can affect synthesis and secretion  of the sex 
hormones and cause infertility.15  In hypopituitarism , 
raised LH and FSH levels may leads  to amenorrhea 
and infertility in women .Further, elevated prolactin 
levels suppress FSH and LH serving as "nature's 
contraceptive.16  
 
Patients and Methods 
 All the subjects were enrolled during August, 2018 to 
January   2019 at Benazir Bhutto Hospital, Rawalpindi. 
A total of 508 samples were included in this study.  
Women with diagnosed primary and secondary 
infertility, in the age bracket of 26-45 year, and having 
marital history of at least one year were included.   
Sserum FSH, LH and Prolactin levels were estimated 
between the 1-5 days of post menstrual period by 
Chemmilumeniscence Immunoassay (CLIA).  The data 
was tested for normality by Shapiro-Wilk test. 
Continuous variables were presented as mean± 
Standard Deviation while categorical variables were 
expressed as frequency (percentages).  Mean levels of 
hormones were  compared with MannWhitney U test. 
Spearmann’s correlation and binay logistic regression 
analysis were used to determine the correlation 
between infertility,hormonal imbalance and other risk 
factors. A two tailed p-value of less than 0.05 was 
considered statistically significant.  
 
Results 
  Mean age of the women enrolled in this study was 
28.7 ± 5.5 years. Majority (88.2%)  of the participants 
belonged to rural areas and 11.8% (n=60) were from 
urban areas(Table 1).  
Table 1: Sociodemographic  characteristics of the 
infertile women. 
Characteristic Groups Frequency Percentage (%) 
    (n= 508)   
  16-25 153 30.1 
Age (years) 26-35 293 57.7 
  36-45 62 12.2 
Residence Rural 448 88.2 
  urban  60 11.8 
Economic level  Adequate 151 29.7 
  
Adequate to 
some extent 310 61 
  Inadequate 47 9.3 
Occupational 
status  Housewife 450 88.6 
  Employer 58 11.4 
Table 2: Educational status 
Educational level Percentage 
Illiterate 21.1 
Read and write 18.7 
Primary 18.5 
Secondary 26.6 
Intermediate 10.6 
Higher studies 4.5 
 
Table 3: Clinical characteristics of  the infertile 
women. 
Characteristics Groups 
Frequency  
(n=508)  
Percentage 
(%) 
   1-3            163         32.1 
Duration of 
infertility 
 4-6            167         32.9 
   7-9            133         26.2 
   >10             45          8.9 
Age at menarche  ≤13            293         57.7  
  ≥14            215         42.3 
Obesity Normal             250         49.2   
  Overweight           258         58.8 
PCOs Present             80         15.7 
  Absent           428         84.3 
Hypertension hypertensive            40          7.9 
  Normal             468         92.1 
Diabetes Present            15          3.0 
  Absent            493        97.0 
T.B Present             20          3.9 
  Absent            488         96.1 
Thyroid disorder Enlarged             29          5.7 
  Normal             479         94.3 
Galactorrhea Present             23            4.3 
  Absent            485         95.5 
Hirusitism Present            145         28.5 
  Absent            363         71.5 
Surgical history Present             122         24 
  Absent            368         76 
 Menstural 
Cycles 
Regular            369         72.6 
  Irregular            139        27.4 
 
Highest percentage (26.6%) of the females had attained 
secondary education(Table 2). Majority (60.4%) of the 
females  had primary infertility. Highest percentage 
(65%) of the females had marital history of up to six 
years, 57.7% of the females were ≤13 years of age at  
menarche, 28.5%  had hirusitism, 27.4% had irregular 
menstrual cycle,19.2 % had hyperprolactenemia, 19.1% 
(n= 97) had acne, 15.7% (n= 80) had PCOS,7.9% (n= 40) 
were hypertensive,5 .7% (n= 29) had enlarged thyroid, 
4.3% (n= 23)  of the females had galactorrhea(Table 
3). A significant positive correlation was found 
between infertility and age (r = 0.110, p- value 0.013 ), 
marital history(r = 0.340, p- value 0.0001 ) and 
Infertility duration (r = 0.137, p- value 0.002 )  
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Table 4: Surgical history 
Surgical history Percentage 
Laparotomy  
 
8.2 
Laparoscopy 
 
5.7 
Appendectomy  
 
4.8 
Thyroidectomy 
 
 
2.5 
Salpingectomy  
 
1.8 
Myomectomy 
 
1 
No Surgical History76% 
 
 
76 
 
Twenty four percent women gave history of a surgical 
procedure (Table 4) FSH levels were significantly 
correlated with age( r = 0.095, p- value 0.05) and 
PCOS( r = 0.162, p- value 0.001). Mean  levels of LH 
(7.58 ±6.37 vs   6.03 ±4.46, p- value .0001) and prolactin 
(19.2 ±14.8 vs 16.0 ±10.8 p- value 0.005) were 
significantly higher in women with primary infertility 
compared to those with secondary infertility 
respectively. No significant difference was observed in 
the mean level of FSH(p-value=0.629) (Table 
5&6;Figure 1&2).   Multivariate logistic regression 
analysis revealed women with secondary infertility 
were more likely to be hypertensive 
(OR=2.126,95%CI:1.020-4.474, p-value0.044).They were 
six times more likely   using contraceptive (OR = 5.876, 
95% CI: 2.491–13.86, p-value .001) compared to 
primary infertile women, had hyperprolactenemia 
(OR=1.289,95%CI:0.960-1.996,p-value0.001) and have 
marital history of more than 16 years 
OR=12.166,95%CI:5.048-29.322, p-value0.001) (Figure 
1&2). 
Table 5: Biochemical infertility risk markers in 
primary and secondary Infertility 
measurement n= 508 
primary 
infertility 
secondary 
infertility p- value 
    n = 309 n= 199   
FSH IU/ml 6.2 ± 3.6  6.31 ±3.81    6.15 ±3.51 0.629  
LH IU/ml 6.9 ± 5.7  7.58 ±6.37   6.03 ±4.46  0.001** 
PRL ng/ml 
17.9 ± 
13.5  19.2 ±14.8   16.0 ±10.8  0.005* 
Table 6: Correlation of FSH,LH and Prolactin with 
other risk factors  for infertility 
Characteristic FSH p value LH p- value Prolactin p-value 
   (r)   (r)     (r)   
Age  
r= 
0.095 
<0.05*  
r= -
0.16 
<0.001*  r= -0.001 >0.05  
PCOS 
r= 
0.162 
<0.001**  
r= -
0.051 
>0.05  r= 0.000 >0.05  
 Menstural Cycles 
r= -
0.124 
<0.001**  
r= 
0.094 
<0.05 * r= -0.027 >0.05  
Galactorrhea 
r= 
0.04  >0.05  
r= 
0.11  <0.05 * r= -0.01  <0.05  
Table 7: Correlation of infertility with other risk 
factors 
Variables r value p value 
 Age  0.110  0.013* 
 Obesity - 0.017  0.708  
 Hypertension  0.088  0.04* 
 Diabetes  0.069  0.123 
 Galactorrhea - 0.058  0.192 
 Hirrusitism  0.043  0.335 
 Thyroid disorder  -0.093  0.360 
 PCOS  0.059  0.184 
 Contraception  0.230  <0.001** 
 FSH  -0.011  0.798 
 LH  0.104  0.019* 
 Prolactin  0.110  0.013* 
 T.B  -0.003  0.939 
Surgical history  0.136  0.002* 
 Menstural  Cycles  0.183  <0.001* 
 Menarche  -0.023  0.598 
 Marital history  0.340  <0.001** 
Infertility duration   0.137  0.002* 
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Figure 1:LH levels in primary and secondary infertile 
women. 
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Figure 2:Prolactin levels in primary and secondary 
infertile women 
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Table 8:Multivariate logistic regression analysis 
Risk factors     OR 95%CI p-value 
    Lower Upper   
 Age (16 years vs 45 years) 2.094 0.953 2.209 0.706 
Obesity(overweight vs 
normal) 
        
0.760 
0.485 1.19 0.23 
 Hirusitism ( yes vs no)        1.005 0.588 1.715 0.987 
 Galactorrhea ( yes vs no) 
        
1.598 
0.606 4.182 0.345 
 Thyroid ( enlarged vs 
normal) 
        
0.438 
0.157 1.22 1.114 
 Infertility duration (1 year 
vs >16) 
         
0.652 
0.359 1.199 0.037* 
 Pcos ( yes vs no) 0.862 0.475 1.566 0.627 
 Diabetes ( yes vs no) 0.315 0.078 1.272 0.331 
 Contraception ( yes vs no) 5.876 2.491 13.86 <0.0001** 
 FSH (1.5 vs 40 microIU/ml ) 0.993 0.936 1.055 0.827 
 LH ( 1.0 vs 41 microIU/ml ) 0.957 0.919 0.996 0.031* 
 PRL ( 2.5 vs 25.1 ng/ml) 1.289 0.96 1.996 0.001* 
 T.B ( yes vs no) 1.461 0.536 3.988 0.485 
 B.P(hypertensive vs ormal) 2.126 1.02 4.474 0.044* 
 Surgical history(yes vs no) 1.191 0.733 1.936 0.481 
Menstrual Cycle(regular vs 
irregular)  
0.957 0.511 1.491 0.618 
 Menarche ( ≤ 13 vs ≥ 14 ) 0.967 0.62 1.478 0.844 
 Marital history (1 year vs 
>16  yr.) 
      12.16 
             
5.048 
        
29.32 
 
<0.0001** 
 
Discussion 
 In current study  60.4% of the females had   primary 
infertility and 39.6% had secondary infertility. Our 
results are in line with  others studies. 17,18 To the 
contrary Sami et al observed higher prevalence of 
secondary infertility  in Pakistan, and Mascarenhas et 
al (2011) observed higher prevalence of secondary 
infertility compared to secondary infertility   in Asian 
countries.4,19 It is suggested that secondary infertile 
females may  opt  to seek consultation less frequently 
because they already had  kids. 
 In present study most affected age group was 26-35 
years.  Similar findings were reported by Adamson et 
al where mean age of infertile women was found to be 
 25.9 years  and Shumaila et al where most affected 
age group was 25-35 years.17,20  Our results are in 
contrast to a Canadian study where most affected age 
group was 35-44 years old.21  It can be ascribed to early 
marriages in Muslim countries. In women 35 years  
and above the risk of impaired fertility increases via 
secondary amenorrhea,PCOs and endometriosis.23  
 In present study a significant positive correlation was 
observed between FSH level and age, FSH level and 
PCOS in the infertile women. This is supported with 
similar study that indicated the significant increase 
levels of FSH with age, this results in disturbances in 
the ovarian functions which are directly correlated 
with infertility.24 Hyperprolactinemia is a prevalent 
complication in reproductive dysfunction affecting 
about 1/3 of infertile women.25,26 It is suggested that 
hyperprolactinemia, at the ovarian level interferes 
with the action of the gonadotrophin and impairs 
gonadal steroid secretion, which in turn alters positive 
feedback effects at the hypothalamic and pituitary 
levels leading to lack of gonadotrophin cyclicity and 
infertility.27 Prolactin may inhibit the follicular 
estradiol   synthesis culminating in infertility.28  
A significantly higher levels of serum LH was found in 
primary infertile women compared to secondary 
infertile group. LH is responsible for ovulation and 
luteinisation and stimulate ovarian theca cells to 
produce androstenedione.29  
 In current study women with secondary infertility 
were more likely to be hypertensive . Chronic 
hypertension is associated with poor ova  quality. 
Pathological contributers to  infertility like PCOs and 
endometriosis may foster hypertension through 
associated metabolic changese e .g  obesity , insulin 
resistance, enhanced estrogen synthesis and 
hyperactive sympathetic nerve. 30,31 Use of oral 
contraceptive alters the hormonal milieu along with 
causing a temporary rise in blood pressure. 32 Most 
commonly used medications for treatment of female 
infertility such as estradiol, leuprolide letrozole  are 
reported to induce hypertension with a prevalence rate 
of 3-7% , 8%  and 5-8% respectively. 33-37An inverse 
relationship between fertility and use of contraceptives 
has been documented from  many  countries. 38,,39,40,41,42  
 
Conclusion 
Highest prevalence of infertility was seen in the age 
group of 26-35 years. Advanced age, hypertension, 
hyperprolacteinemia, use of contraceptive  and marital 
history of more than 16 years   are significantly 
associated with female infertility 
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